Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2025-12-31 @ 5:26 AM
Study NCT ID:
NCT00813995
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2008-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2010-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-19
First Submit QC Date:
None
Study First Post Date:
2008-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-08-09
Results First Submit QC Date:
None
Results First Post Date:
2011-09-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-07
Last Update Post Date:
2017-05-12
Last Update Post Date Type:
ACTUAL